S. Korea Dairy Company CEO Resigns Over Virus Research Scandal

Voice of America
04 May 2021, 20:05 GMT+10

SEOUL, SOUTH KOREA - The chairman of one of South Korea's biggest dairy companies has resigned over a scandal in which his company was accused of deliberately spreading misinformation that its yogurt helps prevent coronavirus infections.

While stepping down as the company's head, Hong Won-sik and other members of his family will retain their commanding share in Namyang Dairy Products.

Namyang financed research it aggressively promoted through the media and a symposium it funded last month that claimed its Bulgaris yogurt drinks were effective in lowering the risk of coronavirus infections.

Namyang's stock price rose temporarily before the Ministry of Food and Drug Safety sued the company for false advertising, saying the research was dubious and never involved any animal testing or clinical trials.

Police searched Namyang's Seoul headquarters last week. Namyang's CEO, Lee Kwang-bum, also offered to resign following a public uproar.

"I express my sincere apology for causing disappointment and anger to our country's people with the Bulgaris-related controversy at a time when the nation is undergoing a hard time because of COVID-19," Hong said, tearing up. He said he will take "all responsibility" by stepping down as chairman and promised not to pass on management rights to his children, which is a much-criticized practice at South Korea's family-owned businesses.

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Japan Herald.

More Information

24 ℃

null in Tokyo

Asia Pacific

Section

China should target Australian military sites, says newspaper editor

China should consider "long-range strikes" if war with the West eventuates, according to an editorial in the country's pro-government newspaper ...

WHO says "low confidence" in Sinopharm Covid side-effects data

GENEVA, Switzerland: World Health Organization experts have said they have "very low confidence" in data received from Chinese state-owned drugmaker ...